Before COVID, India’s diagnostic antibody market was fragmented and import‑dependent. Then the pandemic hit, and local manufacturers like Transasia and Mylab started producing antibody rapid tests at scale. The India antibodies market research study shows that the diagnostic segment is now growing at over 20% annually, driven by a boom in pathology labs and government...
จองคิวบริการ
NR tours
Youplay
NR shop
NR jobs
facebook th
thai 
English
French
Spanish
Portuguese
Italiano
Romaian
Portuguese (Brazil)
china